WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



«Package leaflet: Information for the user Levetiracetam 100 mg/ml oral solution Levetiracetam Read all of this leaflet carefully before you start ...»

Package leaflet: Information for the user

Levetiracetam 100 mg/ml oral solution

Levetiracetam

Read all of this leaflet carefully before you start taking this medicine because it contains important

information for you.

- Keep this leaflet. You may need to read it again.

- If you have any further questions, ask your doctor, or pharmacist or nurse.

- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

- If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1. What Levetiracetam oral solution is and what it is used for

2. What you need to know before you take Levetiracetam oral solution

3. How to take Levetiracetam oral solution

4. Possible side effects

5. How to store Levetiracetam oral solution

6. Contents of the pack and other information

1. What Levetiracetam oral solution is and what it is used for Levetiracetam oral solution is an antiepileptic medicine (a medicine used to treat seizures in epilepsy).

Levetiracetam oral solution is used:

 on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat partial onset seizures with or without secondary generalisation.

 as an add-on to other antiepileptic medicines to treat:

- partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age

- myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy

- primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy

2. What you need to know before you take Levetiracetam oral solution Do not take Levetiracetam oral solution  If you are allergic to levetiracetam or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions Talk to your doctor or pharmacist or nurse before taking Levetiracetam oral solution  If you suffer from kidney problems, follow your doctor’s instructions. He/she may decide if your dose should be adjusted.

 If you notice any slow down in the growth or unexpected puberty development of your child, please contact your doctor.

 If you notice an increase in seizure severity (e.g. increased number), please contact your doctor.

 A small number of people being treated with anti-epileptics such as Levetiracetam oral solution have had thoughts of harming or killing themselves. If you have any symptoms of depression and/or suicidal ideation, please contact your doctor.

Other medicines and Levetiracetam oral solution Tell your doctoror pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

Levetiracetam oral solution with food, drink and alcohol You may take Levetiracetam oral solution with or without food. As a safety precaution, do not take Levetiracetam oral solution with alcohol.

Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Levetiracetam oral solution should not be used during pregnancy unless clearly necessary. A risk of birth defects for your unborn child cannot be completely excluded. Levetiracetam has shown unwanted reproductive effects in animal studies at dose levels higher than you would need to control your seizures.

Breast-feeding is not recommended during treatment.

Driving and using machines Levetiracetam oral solution may impair your ability to drive or operate any tools or machinery, as Levetiracetam oral solution may make you feel sleepy. This is more likely at the beginning of treatment or after an increase in the dose. You should not drive or use machines until it is established that your ability to perform such activities is not affected.

Levetiracetam oral solution contains methyl parahydroxybenzoate, propyl parahydroxybenzoate and maltitol Levetiracetam oral solution includes methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).

Levetiracetam oral solution also contains maltitol (E965). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. How to take Levetiracetam oral solution

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Levetiracetam oral solution must be taken twice a day, once in the morning and once in the evening, at about the same time each day.

Take the oral solution following your doctor’s instructions.

Monotherapy

Dose in adults and adolescents (from 16 years of age) General dose: between 10 ml (1000 mg) and 30 ml (3,000 mg) each day, divided in 2 intakes per day. When you will first start taking Levetiracetam oral solution, your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose.





Add-on therapy Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more General dose: between 10 ml (1,000 mg) and 30 ml (3,000 mg) each day, divided in 2 intakes per day.

–  –  –

Dose in infants (1 month to less than 6 months) General dose: between 0.14 ml (14 mg) and 0.42 ml (42 mg) per kg bodyweight each day, divided in 2 intakes per day. The exact quantity of oral solution formulation should be delivered using the syringe provided in the cardboard box.

–  –  –

Method of administration:

Levetiracetam oral solution may be diluted in a glass of water or baby’s bottle.

Instructions for use:

 Open the bottle: press the cap and turn it anticlockwise (figure 1)  Separate the adaptor from the syringe (figure 2). Insert the adaptor into the bottle neck (figure 3). Ensure it is well fixed.

 Take the syringe and put it in the adaptor opening (figure 4). Turn the bottle upside down (figure 5).

 Fill the syringe with a small amount of solution by pulling the piston down (figure 5A), then push the piston upward in order to remove any possible bubble (figure 5B). Pull the piston down to the graduation mark corresponding to the quantity in milliliters (ml) prescribed by your doctor (figure 5C).

 Turn the bottle the right way up (figure 6A). Remove the syringe from the adaptor (figure 6B).

 Empty the contents of the syringe in a glass of water or baby’s bottle by pushing the piston to the bottom of the syringe (figure 7).

 Drink the whole contents of the glass/baby’s bottle.

 Close the bottle with the plastic screw cap.

 Wash the syringe with water only (figure 8).

Duration of treatment:

 Levetiracetam oral solution is used as a chronic treatment. You should continue Levetiracetam oral solution treatment for as long as your doctor has told you.

 Do not stop your treatment without your doctor’s advice as this could increase your seizures. Should your doctor decide to stop your Levetiracetam oral solution treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam oral solution.

If you take more Levetiracetam oral solution than you should The possible side effects of an overdose of Levetiracetam oral solution are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.

Contact your doctor if you took more Levetiracetam oral solution than you should. Your doctor will establish the best possible treatment of overdose.

If you forget to take Levetiracetam oral solution Contact your doctor if you have missed one or more doses.

Do not take a double dose to make up for a forgotten dose.

If you stop taking Levetiracetam oral solution If stopping treatment, as with other antiepileptic medicines, Levetiracetam oral solution should be discontinued gradually to avoid an increase of seizures.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.

4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some of the side effects like sleepiness, tiredness and dizziness may be more common at the beginning of the treatment or at dose increase. These effects should however decrease over time.

Very common: may affect more than 1 user in 10  nasopharyngitis;

 somnolence (sleepiness), headache.

Common: may affect 1 to 10 users in 100  anorexia (loss of appetite);

 depression, hostility or aggression, anxiety, insomnia, nervousness or irritability;

 convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness), lethargy, tremor (involuntary trembling);

 vertigo (sensation of rotation);

 cough;

 abdominal pain, diarrhoea, dyspepsia (indigestion), vomiting, nausea;

 rash;

 asthenia/fatigue (tiredness).

Uncommon: may affect 1 to 10 users in 1000  decreased number of blood platelets, decreased number of white blood cells;

 weight decrease, weight increase;

 suicide attempt and suicidal ideation, mental disorder, abnormal behaviour, hallucination, anger, confusion, panic attack, emotional instability/mood swings, agitation;

 amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia (impaired coordinated movements), paraesthesia (tingling), disturbance in attention (loss of concentration);

 diplopia (double vision), vision blurred;

 liver function test abnormal;

 hair loss, eczema, pruritus;

 muscle weakness, myalgia (muscle pain);

 injury.

Rare: may affect 1 to 10 users in 10,000  infection;

 decreased number of all blood cell types;

 severe hypersensitivity reactions (DRESS);

 decreased blood sodium concentration;

 suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate);

 uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity);

 pancreatitis;

 hepatic failure, hepatitis;

 skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens- Johnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis).

Reporting of side effects If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Levetiracetam oral solution Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month.

Do not use after 4 months of first opening the bottle.

This medicinal product does not require any special temperature storage conditions. Store in the original container in order to protect from light.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information What Levetiracetam oral solution contains

- The active substance is levetiracetam. Each ml contains 100 mg of levetiracetam.

- The other ingredients are sodium citrate, citric acid monohydrate, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), ammonium glycyrrhizate, glycerol (E422), maltitol liquid (E965), acesulfame potassium (E950), grape flavour containing propylene glycol, purified water.

What Levetiracetam oral solution looks like and contents of the pack

Levetiracetam oral solution is clear, colourless grape flavoured liquid.

The 300 ml glass bottle of Levetiracetam oral solution (for children aged 4 years and above, adolescents and adults) is packed in a cardboard box containing a 10 ml oral syringe (graduated every 0.25 ml) and an adaptor for the syringe.

The 150 ml glass bottle of Levetiracetam oral solution (for infants and young children aged from 6 months to less than 4 years) is packed in a cardboard box containing a 3 ml oral syringe (graduated every 0.1 ml) and an adaptor for the syringe.

The 150 ml glass bottle of Levetiracetam oral solution (for infants aged 1 month to less than 6 months) is packed in a cardboard box containing a 1 ml oral syringe (graduated every 0.05 ml) and an adaptor for the syringe.

Marketing Authorisation Holder Accord Healthcare Limited Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF United Kingdom Manufacturer Accord Healthcare Limited Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF United Kingdom Wessling Hungary Kft.

Budapest, Fóti út 56, 1047, Hungary

This leaflet was last revised in 08/2015.



Similar works:

«Brit. J. Pharmacol. (1965), 25, 338-351.THE METABOLISM OF THALIDOMIDE: THE FATE OF THALIDOMIDE AND SOME OF ITS HYDROLYSIS PRODUCTS IN VARIOUS SPECIES BY H. SCHUMACHER, R. L. SMITH AND R. T. WILLIAMS From the Department of Biochemistry, St. Mary's Hospital Medical School, London, W.2 (Received November 30, 1964) When thalidomide is administered orally to animals, only a small amount of the unchanged drug is excreted in the urine (for example, Beckman, 1962). The major portion of the compound is...»

«      Welcome to Tamana-Gun! The 2013-2014 Guide Ta ble of Contents 1 Welcome and Introduction 2 Area Contacts 3 Calendar of Events 4 – Kumamoto-ken specialties 5-8 – Cities, towns and attractions in and around Tamana 9 –Essentials: Hospitals, Banks, Police, City Hall, Post Office. 10-11– Restaurants 12– Izakayas 13– Bars 14-16 – Shopping 17-18– Entertainment 19 – Sports and Health 20-21 – Transportation A brief Introduction from your Area Leaders, Hugo Dragonetti and...»

«MODULE \ Sexually Transmitted Infections For the Ethiopian Health Center Team Melake Demana, Negga Baraki, Yared Kifle, Fetih Mohammed, Mulusew Getie, Eyob Akililu, Selamawit Debebe, Tamirat Gebru, Mengistu Welday, Alemayehu Galmessa, Yonathan Tadesse, Zinabue Anamo, Fikru Tesfaye Haramaya University In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education 2002 Funded under USAID Cooperative...»

«Mind, Brain, Body, and Behavior Foundations of Neuroscience and Behavioral Research at the National Institutes of Health Ingrid G. Farreras EDITOR-IN-CHIEF Caroline Hannaway EDITOR Victoria A. Harden EDITOR Mind, Brain, Body, and Behavior Biomedical and Health Research Volume 62 Recently published in this series: Vol. 61. J.-F. Stoltz (Ed.), Mechanobiology: Cartilage and Chondrocyte Volume 3 Vol. 60. J.-M. Graf von der Schulenburg and M. Blanke (Eds.), Rationing of Medical Services in Europe:...»

«101 USES FOR THE YOUNG LIVING® THIEVES® PRODUCTS Welcome to the Wonderful World of Thieves® Thieves® Oil Blend was created based on research of a group of 15th century thieves in France who protected themselves by rubbing themselves with cloves, rosemary, and other aromatics while robbing plague victims. This Young Living proprietary blend was university tested and found to be highly effective in supporting the immune system and good health. This proprietary blend has also been documented...»

«COLLEEN E. CLANCY, Ph.D. Department of Physiology and Biophysics Institute for Computational Biomedicine Weill Medical College of Cornell University 1305 York Avenue BOX 140 New York, NY 10021 646-962-6374 clc7003@med.cornell.edu POSITIONS HELD Weill Medical College of Cornell University, New York, NY Assistant Professor of Medicine. 2005 – Assistant Professor of Physiology and Biophysics, and the Institute for Computational Biomedicine. 2004 – Theoretical approaches to structure-function...»

«Dissertation for the degree philosophiae doctor (PhD) at the University of Bergen Dissertation date: 20.01.2015 2 To my wife Daisy and children: Paul, Christopher, Gloria Brenda, Solome, Sammy and daughters Manelli, Sasha, Eva and William for their prayers and encouragement. 3 Sam I Okware Contributors This thesis was made possible through the NUFUfunded collaborative project between the School of Medicine, College of Health Sciences, Makerere University, Kampala, the Ministry of Health Uganda,...»

«Preferred College of Nursing 7400 Van Nuys Blvd. Suite 207 Van Nuys, CA 91405 Tel. No: (818) 902-3708 Fax: (818) 902-3790 Web site: www.pcn.edu School Catalog “We aim to participate in the process of developing self-worthiness, thus enhancing the quality of life, by providing superior level of training in the health care field.” Period Covered: January 04, 2016-January 04, 2017 Print Date: January 04, 2016 IMPORTANT Any questions a student may have regarding this Student Catalog that have...»

«Body Image Perception and Adiposity in School-Age Children by Ofra Duchin A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Environmental Health Sciences) in the University of Michigan 2013 Doctoral committee: Associate Professor Eduardo Villamor, Co-Chair Associate Professor John D. Meeker, Co-Chair Associate Professor Ana Baylin Associate Professor Joyce M. Lee Professor Carlos F. Mendes de Leon “The journey is the reward” ~...»

«A Strategic Plan for Oral Health in Fife 2016-2020 Tell us what you think Have your say on dental care in Fife Introduction Oral health in Scotland has gradually improved since the 1960s and changes in the patterns of disease have occurred in recent years. However, large amounts of dental diseases such as tooth decay and gum disease are still present. These largely preventable conditions are estimated to be among the commonest diseases in the world. These conditions particularly affect those...»

«UNIVERSITY OF MIAMI LEONARD M. MILLER SCHOOL OF MEDICINE CURRICULUM VITAE 1. DATE: April, 2014 I. PERSONAL 2. Name: Nagi George Ayad 3. Home Phone: 786-376-2459 4. Office Phone: 305-243-7695 10561 SW 71st Ave, Pinecrest, FL, 33156 5. Home Address: 6. Current Academic Rank: Associate Professor 7. Primary Department: Psychiatry and Behavioral Sciences 8. Secondary or Joint Appointments: None 9. Citizenship: USA 10. Visa Type (if non-citizen) N/A II. HIGHER EDUCATION 11. Institutional: Rutgers...»

«This report was prepared by Environmental Health Services of the Tropical Population Health Network, Northern Area Health Service, Queensland Health. The report was independently reviewed by an environmental toxicology specialist, Professor Michael Moore. Professor Michael R. Moore Director of the National Research Centre for Environmental Toxicology (EnTox). University of Glasgow; B.Sc., Honours, Biochemistry, 1967; Ph.D., Medicine, 1971D.Sc., Biochemistry in Medicine 1987 Michael is a...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.